WO2004011993A1 - Liquid enzyme preparation for contact lenses - Google Patents

Liquid enzyme preparation for contact lenses Download PDF

Info

Publication number
WO2004011993A1
WO2004011993A1 PCT/JP2003/009426 JP0309426W WO2004011993A1 WO 2004011993 A1 WO2004011993 A1 WO 2004011993A1 JP 0309426 W JP0309426 W JP 0309426W WO 2004011993 A1 WO2004011993 A1 WO 2004011993A1
Authority
WO
WIPO (PCT)
Prior art keywords
contact lenses
water
enzyme
liquid
liquid enzyme
Prior art date
Application number
PCT/JP2003/009426
Other languages
French (fr)
Japanese (ja)
Inventor
Kazuaki Yamamoto
Yusuke Nagai
Masaki Imayasu
Original Assignee
Menicon Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menicon Co., Ltd. filed Critical Menicon Co., Ltd.
Priority to JP2004524142A priority Critical patent/JP4402593B2/en
Priority to AU2003255159A priority patent/AU2003255159A1/en
Publication of WO2004011993A1 publication Critical patent/WO2004011993A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/082Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances in combination with specific enzymes
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0078Compositions for cleaning contact lenses, spectacles or lenses
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38618Protease or amylase in liquid compositions only

Definitions

  • the present invention relates to a liquid enzyme preparation for contact lenses. More specifically, the present invention relates to a liquid enzyme agent which is added to a treatment solution such as a cleaning preservative solution for contact lenses, a disinfectant and a cleaning preservative disinfectant and is brought into contact with the contact lens to remove stains on the contact lens.
  • a treatment solution such as a cleaning preservative solution for contact lenses, a disinfectant and a cleaning preservative disinfectant
  • An object of the present invention is to provide a liquid enzyme agent for a contact lens that does not adversely affect a lens or eye tissue in view of the related art.
  • the present invention relates to a liquid enzyme preparation for contact lenses, comprising a water-soluble organic polymer solid having an average molecular weight of 800 to 1000, a viscosity modifier and an enzyme.
  • the water-soluble high molecular organic solid is preferably a polyalkylene glycol.
  • the water-soluble high-molecular organic solid is preferably polyethylene glycol or polyethylene glycol monomethyl ether.
  • the viscosity modifier is preferably a water-soluble low molecular organic liquid.
  • the liquid enzyme agent for contact lenses preferably contains 5 to 45 wZw% of a water-soluble organic polymer solid.
  • the liquid enzyme preparation for a contact lens preferably contains 15 to 45 w / w% of a viscosity modifier.
  • BEST MODE FOR CARRYING OUT THE INVENTION The liquid enzyme preparation for a contact lens of the present invention contains, as essential components, a water-soluble organic polymer solid having an average molecular weight of 800 to 100000, a viscosity modifier and an enzyme.
  • the enzymes contained in the liquid enzyme agent for contact lenses of the present invention include those that degrade proteins that are the main components of stains in contact lenses and those that degrade other stain components. Specific examples include, but are not limited to, proteolytic enzymes, lipolytic enzymes, and Z or glycolytic enzymes.
  • the water-soluble polymer organic solid used in the present invention means a fluid solid (for example, serine) or a solid, and a water-soluble synthetic polymer organic solid having no micelle-forming ability. Therefore, natural products such as proteins, cellulose, and polysaccharides are not included in the water-soluble high molecular weight organic solids herein.
  • the water-soluble organic polymer solid used in the present invention is not particularly limited as long as it has a mean molecular weight of 800 to 100,000, preferably 1,000 to 20,000. If the average molecular weight is less than 800, the characteristic water retention effect tends not to be exhibited, and if it exceeds 100000, the viscosity when the water-soluble high molecular weight organic solid is dissolved tends to be too high. It is thought that the water-soluble high molecular organic solid contributes to the stabilization of the enzyme by suppressing the hydrolysis reaction of the proteolytic enzyme due to the water retention effect of the polymer chain.
  • water-soluble high molecular weight organic solid in the liquid enzyme agent for contact lenses of the present invention those having extremely high solubility in water (for example, those which dissolve in water at 20 ° C at least 15 w / w%) are preferable. And the viscosity of the solution is high (for example, 1 OPa ⁇ S) even when it is dissolved in multiple parts by weight. Are more preferred. Further, a water-soluble high molecular weight organic solid having a liquid pH in the neutral region after dissolution is also preferable.
  • the water-soluble high molecular organic solid includes, for example, a methyl group bonded to one of the terminal hydroxyl groups of polyethylene glycol, polypropylene glycol, and polyethylene dalicol.
  • Polyalkylene glycols such as polyethylene glycol monomethyl ether, polyvinyl caprolactams such as polyvinylpyrrolidone and poly N-vinylcaprolactam, polyethers such as crown ether, polyacrylamide hydrochloride, polydimethylacrylamide and polyje Use of polyacrylamides such as tylacrylamide, hydroxyl-containing (meth) acrylates such as polyhydroxyethyl methacrylate, or polyols such as polyvinyl alcohol. Can Ru.
  • polyalkylene glycols are preferred from the viewpoints of economy, solubility in water, viscosity of liquid enzyme, safety, and color, among which polyethylene glycol and polyethylene glycol monomethyl ether are preferred. Is more preferred. Among them, those having an average molecular weight of 1000 or more are most preferable.
  • the compounding amount of the water-soluble high molecular weight organic solid in the liquid enzyme preparation for a contact lens of the present invention is preferably 5 to 45 wZw%, more preferably 5 to 20 w / w%. If the amount of the water-soluble high-molecular organic solid is less than 5 wZw%, there is a tendency that the stability of the enzyme, the effect of reducing the osmotic pressure, and the effect of preventing the deformation of the lens are not sufficiently obtained. If it exceeds 45 wZw%, organic solids tend to precipitate when saturation solubility is reached due to temperature changes or the like, and viscosity tends to be too high.
  • the viscosity modifier used in the present invention when used in combination with a water-soluble organic polymer solid, is a more enzymatic agent than when the stability of the enzyme is achieved using only the water-soluble organic polymer solid Can reduce the viscosity.
  • the viscosity modifier when added to the liquid enzyme agent for contact lenses, it has a function of facilitating dripping of the liquid enzyme agent and facilitating mixing of the liquid enzyme agent after dropping with the washing preservation solution.
  • the viscosity of the enzyme agent can be kept low, but the osmotic pressure of the processing solution mixed with the washing preservation solution becomes hypertonic, which may affect the lens or cause misuse.
  • liquid enzyme preparation of the present invention it is important to use a water-soluble organic polymer solid and a viscosity modifier together.
  • a viscosity modifier include, for example, a water-soluble low-molecular-weight organic liquid.
  • the low-molecular organic liquid means an organic liquid that is fluid at normal temperature and normal pressure.
  • glycerin, propylene glycol, low-molecular polypropylene glycol, ethylene glycol, diethylene glycol, etc. can be used as the low-molecular organic liquid.
  • glycerin and propylene glycol are preferred from the viewpoints of enzyme stability, effects on lenses, economy, and performance as a food additive.
  • the amount of the viscosity modifier is less than 15 wZw%, it may not be possible to keep the viscosity of the enzyme agent low. If it is more than 45 w / w%, the osmotic pressure after the treatment may be increased. The lens may be deformed.
  • the liquid enzyme agent for contact lenses of the present invention may contain calcium. Calcium contributes to the stabilization of proteolytic enzymes.
  • the content of calcium in the liquid enzyme preparation for contact lenses of the present invention is preferably 0.05 to 0.05 wZw%, more preferably 0.03 wZw%. More preferred. If it is less than 0.05 wZw%, a sufficient enzyme stability effect tends not to be obtained, and if it is more than 0.05 w / w%, the enzyme tends to be unstable.
  • the liquid enzyme agent for contact lenses of the present invention may contain known auxiliaries such as preservatives, bactericides, pH adjusters (buffers), and / or surfactants.
  • the enzyme can be stably present in the liquid enzyme preparation for contact lenses of the present invention or the final preparation of the enzyme preparation, as long as the enzyme preparation of the present invention is not adversely affected on the subject, human body and environment.
  • the amount of each additive is not limited to the following examples, and can be appropriately set by those skilled in the art.
  • preservatives examples include mercury preservatives such as phenylmercuric nitrate, phenylmercuric acetate and thimerosal, surfactant preservatives such as benzalkonium chloride and pyridinium bromide, chlorhexidine, polyhexamethylene biguanide and Alcohol preservatives such as chlorobutanol, methyl paraben, propyl paraben, dimethyl monodimethylhydantoin, imidazolium perrea, boric acid, boric acid compounds or borax can be used. Among them, one or more substances selected from boric acid, boric acid compounds and borax are preferable, and the amount of addition is 0.00000 to 3.0. It is preferably 0 w / w%.
  • an organic nitrogen-based bactericide is preferable because of its high bactericidal effect at a low concentration, and among these, a biguanide compound or a derivative thereof (a polymer or salt) is more preferable because of its high safety.
  • Polyhexamethylene biguanide (PHMB) is extremely preferred because it has no absorption or absorption.
  • organic nitrogen-based fungicides include, for example, (1) quaternary ammonium compounds or benzalkonium chloride, a polymer thereof, (2) biguanide compounds or their polymers or their salts, such as chlorhexidine dalconate and polyhexamethylene biguanide; and (3) the polymers of the above (1) and (2). It is possible.
  • the amount of the organic nitrogen-based fungicide to be added is about 0.00000001 to 10 w / w%, preferably about 0.00001 to: LwZw%.
  • pH adjusting agent examples include boric acid and its sodium salt, phosphoric acid and its sodium salt, citric acid and its sodium salt, lactic acid and its sodium salt, lactic acid and its amino acid such as glutamine, and its sodium salt It is possible to use, for example, rhium salt or malic acid and its sodium salt.
  • the amount of the pH adjuster added is preferably 0.001 to 3.0 wZw%.
  • any surfactant such as an anionic surfactant, a nonionic surfactant, or a surfactant composed of an anionic surfactant and a nonionic surfactant can be used. Good.
  • anionic surfactants include sodium alkyl sulfate, sodium alkylbenzenesulfonate, sodium alkyl methyl taurine, sodium alkyl sarcosine sodium, one-year-old sodium refine sulfonate, and polyoxyethylene alkyl.
  • Sodium ether phosphate, sodium polyoxyethylene alkyl monodelsulfate, sodium polyoxyethylene alkylphenyl sulfate, sodium di (polyoxyethylene alkyl) phosphate, and the like can be used.
  • the amount of the anionic surfactant added is, for example, 0.01 w / v% or more, preferably 0.02 w / v% or more, and 10 wZv% or less, preferably 5 w / v% or less.
  • Nonionic surfactants include, for example, polyethylene glycol adducts of higher alkylamines and polyethylene glycols of higher fatty acid amides Adducts, polyglycerol esters of higher fatty acids, polyethylene glycol esters of higher fatty acids, polyalkylene glycols of higher fatty acids, polyethylene glycol copolymers, polyhydric alcohol esters of polyethylene glycol of higher fatty acids, higher Polyethylene glycol ethers of alcohols, polyglycerin ethers of higher alcohols, polyethylene glycol ethers of alkylphenols, formaldehyde condensates of polyethylene glycol ethers of alkylene phenols, polypropylene glycol-polyethylene dalicol copolymers, phosphate esters, Use castor oil, hydrogenated castor oil, polyethylene glycol sorbitan alkyl ester, adduct of sterol with polyethylene glycol, etc.
  • Rukoto can.
  • the addition amount of the nonionic surfactant is, for example, not less than 0.01 w / v%, preferably not less than 0.02 w / v%, not more than 10 wZ v%, preferably not more than 5 w / v%. / v% or less.
  • the contents of the anionic surfactant and the nonionic surfactant are within the above ranges, respectively, and the total amount is 0. 0 to 20 w / v%, preferably 0.05 to 10 wZ v%.
  • a dye may be added to the liquid enzyme agent for contact lenses of the present invention.
  • the liquid enzyme agent for contact lenses of the present invention is used after preparing a diluting solution by dropping it into a multi-purpose solution for contact lenses.
  • the multi-purpose solution means a solution that can store, clean, disinfect, and rinse contact lenses in one solution, including a contact lens cleaning preservation solution and a bactericide and a preservative germicide.
  • a contact lens cleaning preservation solution for example, Ines (Distributor: Menicon Inc.)
  • liquid enzyme agent for contact lenses of the present invention will be described in more detail with reference to Examples, but the present invention is not limited to only these Examples.
  • a liquid enzyme preparation for contact lenses of the present invention (Examples 1 to 12), a conventional enzyme preparation comprising only a water-soluble low-molecular organic liquid and a protease (Comparative Examples 1 to 11), a water-soluble low-molecular organic liquid
  • An enzyme preparation comprising a water-soluble high molecular weight organic solid outside the predetermined content of the present invention and a proteolytic enzyme (Comparative Examples 12 and 13) and an enzyme preparation comprising only a water-soluble high molecular weight organic solid and a proteolytic enzyme (Comparative Examples) Examples 14 to 16) were prepared with the compositions described in Tables 1 and 2.
  • * 1 to * 4 used a titration method
  • * 5 used a raw material whose average molecular weight was determined by a viscosity method.
  • Test Example 1 Measurement of residual activity of evening proteinase
  • the residual activity of the protease in each of the enzyme preparations of Examples 1 to 12 and Comparative Examples 1 to 7 and 14 to 16 was measured one week and two weeks after the preparation of the enzyme preparation. However, the enzyme preparations of Examples 11 and 12 were measured one week and one month after the preparation of the enzyme preparation. The measurement was performed as follows.
  • the residual activity (%) was calculated by the following equation.
  • Residual activity value (%) [(AA 0 ) / A Day . ] X 100
  • Tables 3 and 4 show the residual activity value of the enzyme in each enzyme preparation.
  • Test example 2 (Osmotic pressure measurement test in multi-purpose solution)
  • the contact lens enzymatic agents of Examples 1 to 9, 11 and 12, and Comparative Examples 1 to 7 and 14 to 16 were respectively added to a multipurpose solution, and the osmotic pressure of the solution was measured.
  • Ines manufactured by Menicon Co., Ltd.
  • 2 L of Ines was added to each of the enzyme preparations in an amount of 80 L (2 drops).
  • HOSM-1 TOA Electronics Ltd.
  • Tables 5 and 6 show the osmotic pressure of each solution.
  • Test example 3 DIA change measurement test of contact lens
  • the degree of swelling of the lens when continuously immersed in each of the enzyme agents for a certain period was measured. The measurement was performed as follows.
  • a treatment solution was prepared by mixing 2 L of Ines with 80 L of enzyme (equivalent to 2 drops). Next, a contact lens was immersed in each treatment solution.
  • the enzyme preparations of Example 3 and Comparative Example 1 were 1 day and 3 days after the immersion, and the enzyme preparations of Examples 11 and 12 and Comparative Examples 3, 4 and 5 were 1 day after the immersion. Four days later, and for the enzyme preparations of Examples 1, 2, 4, 5, 6, 7, 8 and 9, and Comparative Examples 2, 6, 7, 14, 15 and 16, 1 day and 5 days after immersion
  • the diameter (DIA) of the contact lens was measured. In the test, a frequently interchangeable lens Accuview-1 (manufactured by Johnson & Johnson, water content 58%) was used, and the treatment solution was changed once daily. In DIA measurement, the diameter (A) is measured using the marking on the contact lens as an index, and then the diameter (B) perpendicular to the diameter (A) is measured. Average of diameter (A) and diameter (B) was taken as the DIA measurement value.
  • Tables 7 and 8 show the results of comparing the measured DIA values of the processed lens with those before the processing. Table 7
  • Test example 4 viscosity comparison test of liquid enzyme preparation for contact lens
  • each symbol is: ⁇ : Preferred as a liquid enzyme agent for contact lenses, ⁇ : Degree of use as a liquid enzyme agent for contact lenses, X : Not suitable as liquid enzyme preparation for contact lenses.
  • the change in size before and after lens immersion is 0.05 mm or less
  • ⁇ Change in size before and after lens immersion is greater than 0.05 mm and 0.10 or less
  • ⁇ Osmotic pressure is greater than 45 OmOsmZkg and 50 OmOsmZkg or less
  • X Osmotic pressure is 500 m ⁇ greater than sm / kg
  • At least one item is a ⁇ and the remaining items are ⁇ .
  • Such enzyme agents are preferred as liquid enzyme agents for contact lenses.
  • the corresponding enzyme preparation is not suitable as a liquid enzyme preparation for contact lenses.
  • Test Example 5 Preservation efficacy test
  • test bacteria Five types of bacterial suspensions of Pseudomonas aeruginosa IFO 13275, Staphylococcus aureus IFO 13276, Escherichia coli IFO 3972, Candida albicans IFO 1594, and Aspergillus niger ATCC 16404 were prepared as test bacteria. As test samples, the enzyme preparations of Examples 11 and 12 and Comparative Examples 8 to 13 were used. 100 L of the bacterial suspension was inoculated to 10 mL of the test sample dispensed into the tube and mixed. Each test sample inoculated with the bacteria was placed in 22 incubators overnight and cultured.
  • a saline solution inoculated with the bacteria was serially diluted 10-fold with physiological saline, and Aspergillus niger was spread on the medium (bacteria: SCD LP, fungi: SDLP). Others were pruned.
  • S CD LP medium at 32 ⁇ 2 for 6 days, 30? The medium was cultured at 22 ⁇ 2 ° C for 5 days (3 per group).
  • 0.5 mL was collected from the test sample inoculated with the bacteria, serially diluted 10-fold with physiological saline to determine the number of viable bacteria, and placed in a medium (bacterial: SCDLP, fungus: SDLP).
  • Examples 11 and 12 show that the log reduction is 4 or more for all bacteria and 1 or more for all fungi, It was confirmed that it was excellent.
  • Comparative Examples 8 to 13 none of Examples 11 and 12 obtained a log reduction of 4 or more for all bacteria and 1 or more for all fungi.
  • the largest difference in the composition between the Example and Comparative Example in Test Example 5 is the amount of PEG # 100, and it is possible that the amount of PEG # 100 may have contributed to the storage efficiency of the formulation. The finding was very high. Industrial applicability
  • the water-soluble high molecular organic solid contained in the liquid enzyme agent for contact lenses of the present invention is not taken up by the contact lens and does not have any adverse effect such as swelling of the lens. Therefore, the liquid enzyme agent for contact lenses of the present invention does not impair the lens function.
  • the liquid enzyme preparation for contact lenses of the present invention can prevent an increase in the osmotic pressure of the treatment liquid when the enzyme preparation is dropped, and can suppress adverse effects on the lens and eye irritation during misuse.
  • the liquid enzyme preparation for contact lenses of the present invention has the same enzyme activity stabilizing action as the conventional liquid enzyme preparation for contact lenses (water-soluble low-molecular organic liquid + proteolytic enzyme).
  • the liquid enzyme agent for contact lenses of the present invention has a very excellent effect.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Eyeglasses (AREA)
  • Detergent Compositions (AREA)

Abstract

A liquid enzyme preparation for contact lenses which contains a water-soluble high-molecular weight organic solid having an average molecular weight of 800 to 100000, a viscosity controlling gent and an enzyme. Using this liquid enzyme preparation, it is possible to lessen the swelling or deformation of soft contact lenses, which occur in the case of treating with an existing liquid enzyme preparation for contact lenses (comprising a water soluble low-molecular weight organic liquid and a protease) and irritation of eye tissues due to misuse of an enzyme preparation.

Description

明 糸田 書 コンタクトレンズ用液体酵素剤 技術分野  Akira Itoda Liquid enzyme for contact lenses Technical field
本発明はコンタクトレンズ用液体酵素剤に関する。 さらに詳しくはコン タクトレンズ用洗浄保存液、 殺菌剤および洗浄保存殺菌剤などの処理液に 添加し、 コンタクトレンズに接触させることによりコンタクトレンズの汚 れを除去するための液体酵素剤に関する。 背景技術  The present invention relates to a liquid enzyme preparation for contact lenses. More specifically, the present invention relates to a liquid enzyme agent which is added to a treatment solution such as a cleaning preservative solution for contact lenses, a disinfectant and a cleaning preservative disinfectant and is brought into contact with the contact lens to remove stains on the contact lens. Background art
コンタクトレンズに付着したタンパク質汚れを除去するために、 タンパ ク質分解酵素による分解除去が一般的に行なわれている。 タンパク質分解 酵素を安定化させる手段としては、 有効量のタンパク質分解酵素を錠剤、 顆粒、 粉末などの固形状に形成する方法がとられているが、 この方法では 製造時や使用時に煩雑な手間と時間が必要であるという問題があつた。 こ のような問題を解決するために液状のタンパク質分解酵素剤も開発されて いる。 例えば、 特開平 1一 1 8 0 5 1 5号公報ゃ特開平 2— 1 6 8 2 2 4 号公報においては、 グリセリン、 プロピレングリコール、 ポリエチレング リコールなどの低分子有機液体およびタンパク質分解酵素からなる液体酵 素剤が記載されている。 このような従来技術では、 水溶性低分子有機液体 とタンパク質分解酵素との組合せが多く見られ、 明らかに水溶性低分子有 機液体が酵素の安定化のための主成分として認識されていた。 しかしなが ら、 水溶性低分子有機液体により夕ンパク質分解酵素が安定化された酵素 剤で含水性ソフトコンタクトレンズを処理した場合、 処理液中に含まれる 水溶性低分子有機液体がレンズ内に取り込まれ、 レンズを膨張、 変形させ JP2003/009426 In order to remove protein stains attached to contact lenses, they are generally degraded and removed with proteolytic enzymes. To stabilize proteolytic enzymes, a method of forming an effective amount of the proteolytic enzyme in a solid form such as tablets, granules, and powders has been adopted.However, this method requires complicated labor during production and use. There was a problem that time was required. Liquid proteolytic enzymes have also been developed to solve these problems. For example, Japanese Patent Application Laid-Open No. Hei 11-18015 and Japanese Patent Application Laid-Open No. Hei 2-168224 disclose low molecular weight organic liquids such as glycerin, propylene glycol and polyethylene glycol, and proteolytic enzymes. Liquid enzyme preparations are described. In such prior art, a combination of a water-soluble low-molecular-weight organic liquid and a proteolytic enzyme was often seen, and a water-soluble low-molecular-weight organic liquid was clearly recognized as a main component for stabilizing the enzyme. However, when a water-containing soft contact lens is treated with an enzyme agent that stabilizes protein-degrading enzymes with a water-soluble low-molecular-weight organic liquid, the water-soluble low-molecular-weight organic liquid contained in the treatment liquid will To expand and deform the lens JP2003 / 009426
2 てしまうという問題が生じる。 この問題を回避するため、 市販されている いくつかの夕ンパク質分解酵素剤においては、 一回の使用量は 1滴とする 旨が使用説明書に記載されているが、 誤って数滴使用される場合が少なく ない。 2 There is a problem that To avoid this problem, it is stated in the instruction manual that some of the commercially available protein-degrading enzyme preparations use one drop at a time. Is often done.
また、 このような水溶性低分子有機液体を主成分とする夕ンパク質分解 酵素剤を滴下した処理液の浸透圧は高張となるために、 レンズへの影響や 誤用時の眼組織への刺激なども懸念されている。 発明の開示  In addition, since the osmotic pressure of the treatment solution to which the proteinase-degrading enzyme containing water-soluble low-molecular-weight organic liquid as a main component is dropped is hypertonic, it may affect the lens and irritate the eye tissue when misused. There are also concerns. Disclosure of the invention
本発明は、 前記従来技術に鑑み、 レンズや眼組織への悪影響のないコン タクトレンズ用液体酵素剤を提供することを目的とする。  An object of the present invention is to provide a liquid enzyme agent for a contact lens that does not adversely affect a lens or eye tissue in view of the related art.
本発明は、 平均分子量が 8 0 0〜 1 0 0 0 0 0の水溶性高分子有機固体、 粘性調整剤および酵素を含むコンタクトレンズ用液体酵素剤に関する。 前記コンタクトレンズ用液体酵素剤において、 水溶性高分子有機固体は ポリアルキレングリコール類であることが好ましい。  The present invention relates to a liquid enzyme preparation for contact lenses, comprising a water-soluble organic polymer solid having an average molecular weight of 800 to 1000, a viscosity modifier and an enzyme. In the liquid enzyme preparation for contact lenses, the water-soluble high molecular organic solid is preferably a polyalkylene glycol.
前記コンタクトレンズ用液体酵素剤において、 水溶性高分子有機固体は ポリエチレングリコールまたはポリエチレングリコ一ルモノメチルエーテ ルであることが好ましい。  In the liquid enzyme preparation for contact lenses, the water-soluble high-molecular organic solid is preferably polyethylene glycol or polyethylene glycol monomethyl ether.
前記コンタクトレンズ用液体酵素剤において、 粘性調整剤は水溶性低分 子有機液体であることが好ましい。  In the liquid enzyme agent for contact lenses, the viscosity modifier is preferably a water-soluble low molecular organic liquid.
前記コンタクトレンズ用液体酵素剤は、 水溶性高分子有機固体を 5〜4 5 wZw%含有することが好ましい。  The liquid enzyme agent for contact lenses preferably contains 5 to 45 wZw% of a water-soluble organic polymer solid.
前記コンタクトレンズ用液体酵素剤は、 粘性調整剤を 1 5〜 4 5 w/w %含有することが好ましい。 発明を実施するための最良の形態 本発明のコンタクトレンズ用液体酵素剤は、 必須の成分として、 平均分 子量が 800〜 100000の水溶性高分子有機固体、 粘性調整剤および 酵素を含有する。 The liquid enzyme preparation for a contact lens preferably contains 15 to 45 w / w% of a viscosity modifier. BEST MODE FOR CARRYING OUT THE INVENTION The liquid enzyme preparation for a contact lens of the present invention contains, as essential components, a water-soluble organic polymer solid having an average molecular weight of 800 to 100000, a viscosity modifier and an enzyme.
本発明のコンタクトレンズ用液体酵素剤に含有される酵素とは、 コン夕 クトレンズの汚れの主成分であるタンパク質を分解するもの、 およびその ほかの各汚れ成分を分解するものを包含する。 具体的には、 たとえばタン パク質分解酵素、 脂肪分解酵素および Zまたは糖分解酵素などが挙げられ るが、 これらに限定されるものではない。  The enzymes contained in the liquid enzyme agent for contact lenses of the present invention include those that degrade proteins that are the main components of stains in contact lenses and those that degrade other stain components. Specific examples include, but are not limited to, proteolytic enzymes, lipolytic enzymes, and Z or glycolytic enzymes.
本発明に用いる水溶性高分子有機固体とは、 流動性固体 (たとえば、 ヮ セリンような) または固体であって、 かつミセル形成能をもたない水溶性 合成高分子有機固体を意味する。 したがって、 タンパク質、 セルロースお よび多糖などの天然物は、 本明細書において水溶性高分子有機固体に含ま れない。  The water-soluble polymer organic solid used in the present invention means a fluid solid (for example, serine) or a solid, and a water-soluble synthetic polymer organic solid having no micelle-forming ability. Therefore, natural products such as proteins, cellulose, and polysaccharides are not included in the water-soluble high molecular weight organic solids herein.
本発明に用いる水溶性高分子有機固体としては、 平均分子量が 800〜 100000、 好ましくは 1000〜 20000の水溶性合成高分子有機 固体であればとくに限定されない。 平均分子量が 800未満の場合はその 特徴である水分保持効果が発揮されない傾向があり、 100000を超え る場合は水溶性高分子有機固体を溶解させたときの粘度が高くなりすぎる 傾向がある。 水溶性高分子有機固体は、 高分子鎖が有する水分保持効果に より、 タンパク質分解酵素の加水分解反応を抑制することによって、 酵素 安定化に寄与すると考えられる。  The water-soluble organic polymer solid used in the present invention is not particularly limited as long as it has a mean molecular weight of 800 to 100,000, preferably 1,000 to 20,000. If the average molecular weight is less than 800, the characteristic water retention effect tends not to be exhibited, and if it exceeds 100000, the viscosity when the water-soluble high molecular weight organic solid is dissolved tends to be too high. It is thought that the water-soluble high molecular organic solid contributes to the stabilization of the enzyme by suppressing the hydrolysis reaction of the proteolytic enzyme due to the water retention effect of the polymer chain.
本発明のコンタクトレンズ用液体酵素剤における水溶性高分子有機固体 としては、 水に対する溶解度が非常に高いもの (例えば、 20°Cの水に対 して 15w/w%以上溶解するもの) が好ましく、 かつ多重量部溶解した 場合においても溶液の粘性が高く (例えば、 1 OPa · S) なりすぎない ものがさらに好ましい。 また、 溶解後の液性 p Hが中性領域にある水溶性 高分子有機固体も好ましい。 As the water-soluble high molecular weight organic solid in the liquid enzyme agent for contact lenses of the present invention, those having extremely high solubility in water (for example, those which dissolve in water at 20 ° C at least 15 w / w%) are preferable. And the viscosity of the solution is high (for example, 1 OPa · S) even when it is dissolved in multiple parts by weight. Are more preferred. Further, a water-soluble high molecular weight organic solid having a liquid pH in the neutral region after dissolution is also preferable.
本発明のコンタクトレンズ用液体酵素剤において、 水溶性高分子有機固 体としては、 たとえば、 ポリエチレングリコ一ル、 ポリプロピレングリコ —ル、 およびポリエチレンダリコールの末端水酸基の一方にメチル基がェ 一テル結合したポリエチレングリコ—ルモノメチルェ一テルなどのポリア ルキレングリコール類、 ポリビニルピロリドンおよびポリ N—ビニルカプ ロラクタムなどのポリビニルカプロラクタム類、 クラウンエーテルなどの ポリエーテル類、 ポリアクリルアミド塩酸塩、 ポリジメチルアクリルアミ ドおよびポリジェチルァクリルアミドなどのポリアクリルアミド類、 ポリ ヒドロキシェチルメ夕ァクリレートなどの水酸基含有 (メタ) ァクリレ一 ト類またはポリビエルアルコールなどのポリオ一ル類を用いることができ る。 水溶性高分子有機固体の中でも、 経済面、 水に対する溶解度、 液体酵 素剤の粘度、 安全性、 色などの理由からポリアルキレングリコール類が好 ましく、 その中でもポリエチレングリコールおよびポリエチレングリコー ルモノメチルェ一テルがさらに好ましい。 それらの中でも平均分子量 1 0 0 0以上のものが最も好ましい。  In the liquid enzyme preparation for contact lenses of the present invention, the water-soluble high molecular organic solid includes, for example, a methyl group bonded to one of the terminal hydroxyl groups of polyethylene glycol, polypropylene glycol, and polyethylene dalicol. Polyalkylene glycols such as polyethylene glycol monomethyl ether, polyvinyl caprolactams such as polyvinylpyrrolidone and poly N-vinylcaprolactam, polyethers such as crown ether, polyacrylamide hydrochloride, polydimethylacrylamide and polyje Use of polyacrylamides such as tylacrylamide, hydroxyl-containing (meth) acrylates such as polyhydroxyethyl methacrylate, or polyols such as polyvinyl alcohol. Can Ru. Among water-soluble high molecular weight organic solids, polyalkylene glycols are preferred from the viewpoints of economy, solubility in water, viscosity of liquid enzyme, safety, and color, among which polyethylene glycol and polyethylene glycol monomethyl ether are preferred. Is more preferred. Among them, those having an average molecular weight of 1000 or more are most preferable.
本発明のコン夕クトレンズ用液体酵素剤における水溶性高分子有機固体 の配合量は、 5〜4 5 wZw%とするのが好ましく、 5〜2 0 w/w%と するのがさらに好ましい。 水溶性高分子有機固体の配合量が、 5 wZw% 未満の場合は、 酵素の安定性、 浸透圧の軽減効果およびレンズの変形防止 効果が充分に得られない傾向がある。 4 5 wZw%より多くなると、 温度 変化などの理由で飽和溶解度に達したときに有機固体が析出する傾向、 お よび粘性が高くなりすぎる傾向がある。  The compounding amount of the water-soluble high molecular weight organic solid in the liquid enzyme preparation for a contact lens of the present invention is preferably 5 to 45 wZw%, more preferably 5 to 20 w / w%. If the amount of the water-soluble high-molecular organic solid is less than 5 wZw%, there is a tendency that the stability of the enzyme, the effect of reducing the osmotic pressure, and the effect of preventing the deformation of the lens are not sufficiently obtained. If it exceeds 45 wZw%, organic solids tend to precipitate when saturation solubility is reached due to temperature changes or the like, and viscosity tends to be too high.
本発明に用いる粘性調整剤とは、 水溶性高分子有機固体と併用すること で、 水溶性高分子有機固体のみで酵素の安定性を図つた場合よりも酵素剤 の粘性を下げることができるものである。 つまり、 粘性調整剤はコンタク トレンズ用液体酵素剤に添加することにより、 液体酵素剤を滴下しやすく し、 滴下後の液体酵素剤を洗浄保存液と混和させやすくする働きを有する。 ただし、 粘性調整剤のみで酵素の安定化を図つた場合では酵素剤の粘性を 低く保つことはできるが、 洗浄保存液と混和した処理液の浸透圧が高張と なり、 レンズへの影響や誤用時の眼組織への刺激なども懸念される。 した がって、 本発明における液体酵素剤では、 水溶性高分子有機固体と粘性調 整剤を併用することが重要である。 このような粘性調整剤の具体例として は、 たとえば水溶性低分子有機液体などが挙げられる。 The viscosity modifier used in the present invention, when used in combination with a water-soluble organic polymer solid, is a more enzymatic agent than when the stability of the enzyme is achieved using only the water-soluble organic polymer solid Can reduce the viscosity. In other words, by adding the viscosity modifier to the liquid enzyme agent for contact lenses, it has a function of facilitating dripping of the liquid enzyme agent and facilitating mixing of the liquid enzyme agent after dropping with the washing preservation solution. However, when the enzyme is stabilized only with a viscosity modifier, the viscosity of the enzyme agent can be kept low, but the osmotic pressure of the processing solution mixed with the washing preservation solution becomes hypertonic, which may affect the lens or cause misuse. There are also concerns about irritation of the eye tissue at the time. Therefore, in the liquid enzyme preparation of the present invention, it is important to use a water-soluble organic polymer solid and a viscosity modifier together. Specific examples of such a viscosity modifier include, for example, a water-soluble low-molecular-weight organic liquid.
前記低分子有機液体とは、 常温、 常圧で流体性のある有機液体を意味す る。 本発明のコンタクトレンズ用液体酵素剤においては、 低分子有機液体 として、 たとえば、 グリセリン、 プロピレングリコール、 低分子ポリプロ ピレングリコール、 エチレングリコール、 ジエチレングリコールなどを用 いることができる。 低分子有機液体の中でも、 酵素安定性効果、 レンズへ の影響、 経済面、 食品添加物としての実績の点から、 グリセリン、 プロピ レングリコールが好ましい。  The low-molecular organic liquid means an organic liquid that is fluid at normal temperature and normal pressure. In the liquid enzyme preparation for contact lenses of the present invention, for example, glycerin, propylene glycol, low-molecular polypropylene glycol, ethylene glycol, diethylene glycol, etc. can be used as the low-molecular organic liquid. Among low molecular weight organic liquids, glycerin and propylene glycol are preferred from the viewpoints of enzyme stability, effects on lenses, economy, and performance as a food additive.
本発明のコンタクトレンズ用液体酵素剤における粘性調整剤の配合量は、 The compounding amount of the viscosity modifier in the liquid enzyme agent for contact lenses of the present invention,
1 5〜4 5 w/w%とするのが好ましく、 2 0〜4 0 w/w%とするのが さらに好ましい。 粘性調整剤の配合量が、 1 5 wZw%未満の場合、 酵素 剤の粘度を低く保つことができない可能性があり、 4 5 w/w%より多く なると、 処理後の浸透圧を高くさせたり、 レンズを変形させたりする恐れ がある。 It is preferably from 15 to 45 w / w%, more preferably from 20 to 40 w / w%. If the amount of the viscosity modifier is less than 15 wZw%, it may not be possible to keep the viscosity of the enzyme agent low.If it is more than 45 w / w%, the osmotic pressure after the treatment may be increased. The lens may be deformed.
本発明のコンタクトレンズ用液体酵素剤は、 カルシウムを含有してもよ い。 カルシウムは、 タンパク質分解酵素の安定化に寄与する。 本発明のコ ンタクトレンズ用液体酵素剤におけるカルシウムの配合量は、 0 . 0 0 5 〜0 . 0 5 wZw%とするのが好ましく、 0 . 0 3 wZw%とするのがよ り好ましい。 0 . 0 0 5 wZw%未満の場合は、 充分な酵素安定性効果が 得られない傾向があり、 0 . 0 5 w/w%より多い場合は、 酵素を不安定 化する傾向がある。 The liquid enzyme agent for contact lenses of the present invention may contain calcium. Calcium contributes to the stabilization of proteolytic enzymes. The content of calcium in the liquid enzyme preparation for contact lenses of the present invention is preferably 0.05 to 0.05 wZw%, more preferably 0.03 wZw%. More preferred. If it is less than 0.05 wZw%, a sufficient enzyme stability effect tends not to be obtained, and if it is more than 0.05 w / w%, the enzyme tends to be unstable.
本発明のコンタクトレンズ用液体酵素剤は、 防腐剤、 殺菌剤、 p H調整 剤 (緩衝剤) 、 および/または界面活性剤などの公知の助剤を含んでもよ レ^ これらの助剤は、 本発明のコンタクトレンズ用液体酵素剤または該酵 素剤の最終調製液において酵素が安定に存在することができ、 本発明の酵 素剤を適用する対象、 人体、 環境に悪影響を及ぼさない限りとくに制限さ れない。 また、 各助剤の添加量は、 以下の例示に限定されるものではなぐ 当業者により適宜設定され得る。  The liquid enzyme agent for contact lenses of the present invention may contain known auxiliaries such as preservatives, bactericides, pH adjusters (buffers), and / or surfactants. Particularly, the enzyme can be stably present in the liquid enzyme preparation for contact lenses of the present invention or the final preparation of the enzyme preparation, as long as the enzyme preparation of the present invention is not adversely affected on the subject, human body and environment. Not restricted. Further, the amount of each additive is not limited to the following examples, and can be appropriately set by those skilled in the art.
前記防腐剤としては、 たとえば、 硝酸フエニル水銀、 酢酸フエニル水銀 およびチメロサールなどの水銀系防腐剤、 塩化ベンザルコニゥムおよび臭 化ピリジニゥムなどの界面活性剤系防腐剤、 クロルへキシジン、 ポリへキ サメチレンビグアニドおよびクロロブタノ—ルなどのアルコール系防腐剤、 メチルパラベン、 プロピルパラベン、 ジメチ口一ルジメチルヒダントイン、 イミダゾリウムゥレア、 ホウ酸、 ホウ酸化合物またはホウ砂などを用いる ことができる。 その中で好ましいものは、 ホウ酸、 ホウ酸化合物およびホ ゥ砂の中から選ばれた 1つ、 もしくは 2つ以上の物質であり、 その添加量 は、 0 . 0 0 0 0 1〜3 . 0 w/w%であることが好ましい。  Examples of the preservative include mercury preservatives such as phenylmercuric nitrate, phenylmercuric acetate and thimerosal, surfactant preservatives such as benzalkonium chloride and pyridinium bromide, chlorhexidine, polyhexamethylene biguanide and Alcohol preservatives such as chlorobutanol, methyl paraben, propyl paraben, dimethyl monodimethylhydantoin, imidazolium perrea, boric acid, boric acid compounds or borax can be used. Among them, one or more substances selected from boric acid, boric acid compounds and borax are preferable, and the amount of addition is 0.00000 to 3.0. It is preferably 0 w / w%.
前記殺菌剤としては、 低濃度で殺菌効果が高いことから有機チッ素系殺 菌剤が好ましく、 なかでも安全性が高いことからビグァニド化合物または その誘導体 (重合物や塩) がより好ましく、 とりわけレンズへの吸収、 吸 着がないことからポリへキサメチレンビグアニド (P HM B) が極めて好 ましい。  As the bactericide, an organic nitrogen-based bactericide is preferable because of its high bactericidal effect at a low concentration, and among these, a biguanide compound or a derivative thereof (a polymer or salt) is more preferable because of its high safety. Polyhexamethylene biguanide (PHMB) is extremely preferred because it has no absorption or absorption.
前記有機チッ素系殺菌剤の代表例としては、 たとえば (1 ) 4級アンモ ニゥム化合物またはその重合物である塩化ベンザルコニゥム、 塩化べンゼ トニゥム、 ダイマ一 136など、 (2) ビグアニド化合物またはその重合 物またはその塩であるダルコン酸クロルへキシジン、 ポリへキサメチレン ビグアニドなど、 (3) 前記 (1) および (2) の重合物などがあげられ る。 有機チッ素系殺菌剤の添加量は、 0. 000001〜10 w/w%程 度、 好ましくは 0. 00001〜: LwZw%程度である。 Representative examples of the organic nitrogen-based fungicides include, for example, (1) quaternary ammonium compounds or benzalkonium chloride, a polymer thereof, (2) biguanide compounds or their polymers or their salts, such as chlorhexidine dalconate and polyhexamethylene biguanide; and (3) the polymers of the above (1) and (2). It is possible. The amount of the organic nitrogen-based fungicide to be added is about 0.00000001 to 10 w / w%, preferably about 0.00001 to: LwZw%.
前記 pH調整剤 (緩衝剤) としては、 たとえば、 ホウ酸とそのナトリウ ム塩、 リン酸とそのナトリウム塩、 クェン酸とそのナトリウム塩、 乳酸と そのナトリゥム塩、 ダリシンまたはグルタミンなどのアミノ酸とそのナト リゥム塩、 またはリンゴ酸とそのナトリゥム塩などを使用することができ る。 PH調整剤の添加量は、 0. 001〜3. 0wZw%であることが好 ましい。  Examples of the pH adjusting agent (buffering agent) include boric acid and its sodium salt, phosphoric acid and its sodium salt, citric acid and its sodium salt, lactic acid and its sodium salt, lactic acid and its amino acid such as glutamine, and its sodium salt It is possible to use, for example, rhium salt or malic acid and its sodium salt. The amount of the pH adjuster added is preferably 0.001 to 3.0 wZw%.
前記界面活性剤としては、 たとえば、 ァニオン系界面活性剤、 ノニオン 系界面活性剤、 またはァニオン系界面活性剤とノ二オン系界面活性剤とか らなるものなど、 いずれの界面活性剤を用いてもよい。  As the surfactant, any surfactant such as an anionic surfactant, a nonionic surfactant, or a surfactant composed of an anionic surfactant and a nonionic surfactant can be used. Good.
ァニオン系界面活性剤としては、 たとえばアルキル硫酸ナトリウム、 ァ ルキルべンゼンスルホン酸ナトリウム、 アルキロィルメチルタウリンナト リウム、 アルキロイルザルコシンナ卜リゥム、 一才レフインスルホン酸 ナトリウム、 ポリォキシエチレンアルキルェ一テルリン酸ナトリウム、 ポ リォキシェチレンアルキル 一デル硫酸ナトリウム、 ポリオキシェチレン アルキルフエ二ルェ一テル硫酸ナトリウム、 ジ (ポリオキシエチレンアル キルェ一テル) リン酸ナトリウムなどを使用することができる。 ァニオン 系界面活性剤の添加量は、 たとえば、 0. 01w/v%以上、 好ましくは 0. 02w/v%以上であって、 10wZv%以下、 好ましくは 5w/v %以下である。  Examples of anionic surfactants include sodium alkyl sulfate, sodium alkylbenzenesulfonate, sodium alkyl methyl taurine, sodium alkyl sarcosine sodium, one-year-old sodium refine sulfonate, and polyoxyethylene alkyl. Sodium ether phosphate, sodium polyoxyethylene alkyl monodelsulfate, sodium polyoxyethylene alkylphenyl sulfate, sodium di (polyoxyethylene alkyl) phosphate, and the like can be used. The amount of the anionic surfactant added is, for example, 0.01 w / v% or more, preferably 0.02 w / v% or more, and 10 wZv% or less, preferably 5 w / v% or less.
ノニオン系界面活性剤としては、 たとえば、 高級アルキルァミンのポリ エチレングリコール付加物、 高級脂肪酸アミドのポリエチレングリコール 付加物、 高級脂肪酸のポリグリセリンエステル、 高級脂肪酸のポリエチレ ングリコールエステル、 高級脂肪酸のポリアルキレングリコ一ル、 ポリエ チレングリコールコポリマ一エステル、 高級脂肪酸のポリエチレングリコ —ルの付加した多価アルコールエステル、 高級アルコールのポリエチレン グリコールエーテル、 高級アルコールのポリグリセリンエーテル、 アルキ ルフエノールのポリェチレングリコ一ルエーテル、 アルキレンフエノール のポリエチレングリコールエーテルのホルムアルデヒド縮合物、 ポリプロ ピレンダリコール—ポリエチレンダリコール共重合体、 リン酸エステル、 ヒマシ油、 硬化ヒマシ油、 ポリエチレングリコ一ルソルビタンアルキルェ ステル、 ステロールのポリエチレングリコール付加物などを用いることが できる。 ノニオン系界面活性剤の添加量は、 たとえば、 0 . 0 1 w/ v % 以上、 好ましくは 0 . 0 2 w/v %以上であって、 1 0 wZ v %以下、 好 ましくは 5 w/v %以下である。 Nonionic surfactants include, for example, polyethylene glycol adducts of higher alkylamines and polyethylene glycols of higher fatty acid amides Adducts, polyglycerol esters of higher fatty acids, polyethylene glycol esters of higher fatty acids, polyalkylene glycols of higher fatty acids, polyethylene glycol copolymers, polyhydric alcohol esters of polyethylene glycol of higher fatty acids, higher Polyethylene glycol ethers of alcohols, polyglycerin ethers of higher alcohols, polyethylene glycol ethers of alkylphenols, formaldehyde condensates of polyethylene glycol ethers of alkylene phenols, polypropylene glycol-polyethylene dalicol copolymers, phosphate esters, Use castor oil, hydrogenated castor oil, polyethylene glycol sorbitan alkyl ester, adduct of sterol with polyethylene glycol, etc. Rukoto can. The addition amount of the nonionic surfactant is, for example, not less than 0.01 w / v%, preferably not less than 0.02 w / v%, not more than 10 wZ v%, preferably not more than 5 w / v%. / v% or less.
ァニオン系界面活性剤とノニオン系界面活性剤とを併用する場合、 ァニ オン系界面活性剤およびノ二オン系界面活性剤の含有量は、 それぞれ前記 した範囲内でかつ、 合計量が 0. 0 2〜2 0 w/v %、 好ましくは 0. 0 5 〜1 0 wZ v %である。  When an anionic surfactant and a nonionic surfactant are used in combination, the contents of the anionic surfactant and the nonionic surfactant are within the above ranges, respectively, and the total amount is 0. 0 to 20 w / v%, preferably 0.05 to 10 wZ v%.
このほか、 本発明のコンタクトレンズ用液体酵素剤には、 色素を添加し ても良い。  In addition, a dye may be added to the liquid enzyme agent for contact lenses of the present invention.
本発明のコンタクトレンズ用液体酵素剤は、 コンタクトレンズ用マルチ パーパスソリューションに滴下して希釈液を調製したのち使用する。 なお、 マルチパーパスソリューションとは、 コンタクトレンズ用洗浄保存液なら びに殺菌剤および洗浄保存殺菌剤などを含む、 コンタクトレンズの保存、 洗浄、 消毒、 すすぎを一液で行なうことができる液剤を意味する (たとえ ば、 アイネス (販売元:株式会社メニコン) ) 。 得られた希釈液にコンタ クトレンズを一定時間浸漬せしめることで、 コンタクトレンズに付着した タンパク質などの汚れ成分をこすり洗いすることなく、 除去することがで さる。 The liquid enzyme agent for contact lenses of the present invention is used after preparing a diluting solution by dropping it into a multi-purpose solution for contact lenses. The multi-purpose solution means a solution that can store, clean, disinfect, and rinse contact lenses in one solution, including a contact lens cleaning preservation solution and a bactericide and a preservative germicide. For example, Ines (Distributor: Menicon Inc.)). By immersing the contact lens in the obtained diluent for a certain period of time, the contact lens adhered to the contact lens. Dirt components such as proteins can be removed without scrubbing.
以下、 本発明のコンタクトレンズ用液体酵素剤を実施例によってさらに 詳細に説明するが、 本発明はかかる実施例のみに限定されるものではな い。  Hereinafter, the liquid enzyme agent for contact lenses of the present invention will be described in more detail with reference to Examples, but the present invention is not limited to only these Examples.
実施例 1〜 12、 比較例 1〜 16 Examples 1 to 12, Comparative Examples 1 to 16
本発明のコンタクトレンズ用液体酵素剤 (実施例 1〜12) 、 水溶性低 分子有機液体のみとタンパク質分解酵素とからなる従来の酵素剤 (比較例 1〜11) 、 水溶性低分子有機液体と、 本発明の所定含有量外の水溶性高 分子有機固体とタンパク質分解酵素とからなる酵素剤 (比較例 12、 13 ) および水溶性高分子有機固体のみとタンパク質分解酵素とからなる酵素 剤 (比較例 14〜16) を表 1および 2に記載の組成で調製した。 A liquid enzyme preparation for contact lenses of the present invention (Examples 1 to 12), a conventional enzyme preparation comprising only a water-soluble low-molecular organic liquid and a protease (Comparative Examples 1 to 11), a water-soluble low-molecular organic liquid An enzyme preparation comprising a water-soluble high molecular weight organic solid outside the predetermined content of the present invention and a proteolytic enzyme (Comparative Examples 12 and 13) and an enzyme preparation comprising only a water-soluble high molecular weight organic solid and a proteolytic enzyme (Comparative Examples) Examples 14 to 16) were prepared with the compositions described in Tables 1 and 2.
実施例 配合組成 Example Formulation composition
1 2 3 4 5 6 7 8 フロヒレンクリコ一レ 20 20 20 30 0 0 0 0 グリセリン 0 0 0 0 30 20 20 30 3 1 2 3 4 5 6 7 8 Floheren Clicoret 20 20 20 30 0 0 0 0 Glycerin 0 0 0 0 30 20 20 30 3
PEG# 200 *1 0 0 0 0 0 0 0 0PEG # 200 * 1 0 0 0 0 0 0 0 0
PEG# 1000 " 40 0 0 33.5 33.5 20 0 20PEG # 1000 "40 0 0 33.5 33.5 20 0 20
PEG#4000 *3 0 40 0 0 0 0 0 0PEG # 4000 * 3 0 40 0 0 0 0 0 0
PEG— Me # 2000 0 0 40 0 0 0 20 0 2PEG—Me # 2000 0 0 40 0 0 0 20 0 2
P— NVP#10000*5 0 0 0 0 0 0 0 0 蛋白質分解酵素 A * 6 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0. 蛋白質分解酵素 B *7 0 0 0 0 0 0 0 0 ホウ砂 0 0 0 0 0 0 0 0 色素 0 0 0 0 0 0 0 0 lOmM Tris-HCl (pH=8.0) 残部 残部 残部 残部 残部 残部 残部 残部 残 水 0 0 0 0 0 0 0 0 P— NVP # 10000 * 5 0 0 0 0 0 0 0 0 Protease A * 6 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0. Protease B * 7 0 0 0 0 0 0 0 0 Borax 0 0 0 0 0 0 0 0 Dye 0 0 0 0 0 0 0 0 lOmM Tris-HCl (pH = 8.0) Remaining Remaining Remaining Remaining Remaining Remaining Remaining Remaining Remaining water 0 0 0 0 0 0 0 0
表 2 比較例 Table 2 Comparative example
配合組成 Composition
1 2 3 4 5 6 7 8 9 10 11 プロピレングリコール n π π 20 0 0 0 0 グリセリン 0 0 20 40 60 o o 31.5 36 40.5 45 1 2 3 4 5 6 7 8 9 10 11 Propylene glycol n π π 20 0 0 0 0 Glycerin 0 0 20 40 60 oo 31.5 36 40.5 45
PEG# 200 *λ 0 0 0 0 0 60 40 0 0 0 0PEG # 200 * λ 0 0 0 0 0 60 40 0 0 0 0
PEG# 1000 *2 0 0 0 0 0 0 0 0 0 0 0PEG # 1000 * 2 0 0 0 0 0 0 0 0 0 0 0
PEG#4000 *3 0 0 0 0 0 0 0 0 0 0 0PEG # 4000 * 3 0 0 0 0 0 0 0 0 0 0 0
PEG— Me#2000 *4 0 0 0 0 0 0 0 0 0 0 0 蛋白質分解酵素 A *6 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0 0 0 0 蛋白質分解酵素 B *7 0 0 0 0 0 0 0 2.7 2.7 2.7 2.7 ホウ砂 0 0 0 0 0 0 0 3.3 3.3 3.3 3.3 色素 0 0 0 0 0 0 0 0.0013 0.0013 0.0013 0.0013 0.PEG—Me # 2000 * 400 0 0 0 0 0 0 0 0 0 0 Protease A * 6 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0 0 0 0 Protease B * 7 0 0 0 0 0 0 0 2.7 2.7 2.7 2.7 Borax 0 0 0 0 0 0 0 3.3 3.3 3.3 3.3 Dye 0 0 0 0 0 0 0 0.0013 0.0013 0.0013 0.0013 0.
10mM Tris-HCl (pH=8.0)残部残部残部残部残部残部残部 0 0 0 0 水 0 0 0 0 0 0 0 残部 残部 残部 残部 10 mM Tris-HCl (pH = 8.0) Remaining Remaining Remaining Remaining Remaining Remaining Remaining 0 0 0 0 Water 0 0 0 0 0 0 0 Remaining Remaining Remaining Remaining
なお、 表 1および 2において、 * 1〜* 7は以下のものを示す。 In Tables 1 and 2, * 1 to * 7 indicate the following.
* 1 :ポリエチレングリコ一ル (平均分子量約 200、 液体、 ナカラィテ3 スク株式会社製) * 1: Polyethylene glycol (average molecular weight: about 200, liquid, manufactured by Nacalite 3 Disc Co., Ltd.)
* 2 :ポリエチレングリコール (平均分子量約 1000、 固体、 ナカライ テスク株式会社製)  * 2: Polyethylene glycol (average molecular weight about 1000, solid, manufactured by Nacalai Tesque, Inc.)
* 3 :ポリエチレングリコール (平均分子量約 4000、 固体、 ナカライ テスク株式会社製)  * 3: Polyethylene glycol (average molecular weight about 4000, solid, manufactured by Nacalai Tesque, Inc.)
* 4 :ポリエチレングリコールモノメチルェ一テル (平均分子量約 2000、 固体、 アルドリッチケミカル社 (Aldrich Chemical Co即 any Inc.) 製) * 4: Polyethylene glycol monomethyl ether (average molecular weight: about 2,000, solid, manufactured by Aldrich Chemical Co., Inc. any Inc.)
* 5 :ポリビニルピロリドン (平均分子量約 10000、 固体、 東京化成 工業株式会社製) * 5: Polyvinylpyrrolidone (average molecular weight about 10,000, solid, manufactured by Tokyo Chemical Industry Co., Ltd.)
* 6 : C l e a rLen s -P r o 2. 0 L (ノポェンザィム社製) * 6: Cle aLenS -Pro 2.0 L (manufactured by Nopoenzym)
* 7 : CL- 5 PG (ナガセケムテックス株式会社製) * 7: CL-5 PG (manufactured by Nagase ChemteX Corporation)
また、 * 1〜 * 4は滴定法、 * 5は粘度法により平均分子量を求めた原 材料を使用した。  In addition, * 1 to * 4 used a titration method, and * 5 used a raw material whose average molecular weight was determined by a viscosity method.
各酵素剤に対し、 タンパク質分解酵素の残存活性測定、 マルチパーパス ソリユーション中での浸透圧測定試験、 コンタクトレンズのサイズ変化測 定試験を実施した。 また、 実施例 11、 12、 比較例 8〜 13については 保存効力試験も実施した。  For each enzyme preparation, the residual activity of the proteolytic enzyme, the osmotic pressure measurement test in a multipurpose solution, and the contact lens size change measurement test were performed. Further, for Examples 11 and 12, and Comparative Examples 8 to 13, preservation efficacy tests were also performed.
試験例 1 (夕ンパク質分解酵素の残存活性測定) Test Example 1 (Measurement of residual activity of evening proteinase)
実施例 1〜 12ならびに比較例 1〜7ぉょび14〜16の各酵素剤中の タンパク質分解酵素の残存活性を、 酵素剤の調製から 1週間後および 2週 間後に測定した。 ただし、 実施例 11および 12の酵素剤については、 酵 素剤の調製から 1週間後および 1力月後に測定した。 測定は以下のように 行なった。  The residual activity of the protease in each of the enzyme preparations of Examples 1 to 12 and Comparative Examples 1 to 7 and 14 to 16 was measured one week and two weeks after the preparation of the enzyme preparation. However, the enzyme preparations of Examples 11 and 12 were measured one week and one month after the preparation of the enzyme preparation. The measurement was performed as follows.
37°Cに加温した 2. 0%カゼイン溶液 (pH8、 0. 05Mトリス— 水酸化ナトリゥム水溶液) 4 m Lに、 希釈液 (pH8、 10 mMトリスー 塩酸水溶液) 3. 6mLおよび酵素剤 0. 4 mLを混和した。 混和後、 た だちに、 その lmLを 0. 4Mトリクロ口酢酸水溶液 lmLに添加、 混合 することにより未分解カゼインを沈殿させた。 この操作は 3回行い、 3つ のサンプル (n=3) を得た。 その各々の上澄み液中のカゼイン分解物に よる 280 nmにおける初期吸収値をそれぞれ測定し、 3つの初期吸収測 定結果の平均値 A。を求めた。 残りの 5mLは 37°Cで 10分間保ち、 そ の 1 mLを用いて前記沈殿法により未分解カゼィンを沈殿させた。 この操 作を 4回行い、 4つのサンプル (n = 4) を得た。 その各々の上澄み液中 の 280 nmにおける処理後吸収値を測定し、 4つの処理後吸収結果の平 均値 Aを求めた。 処理後吸収平均値 Aより初期吸収平均値 A。を差し引い たものを夕ンパク質分解酵素の活性値とした。 2.0% casein solution (pH 8, 0.05M Tris To 4 mL of an aqueous sodium hydroxide solution, 3.6 mL of a diluent (pH 8, 10 mM aqueous Tris-HCl solution) and 0.4 mL of an enzyme preparation were mixed. Immediately after mixing, 1 mL of the resulting solution was added to 1 mL of a 0.4 M aqueous solution of trichloroacetic acid, and mixed to precipitate undegraded casein. This operation was performed three times to obtain three samples (n = 3). The initial absorption values at 280 nm due to the casein hydrolyzate in each supernatant were measured, and the average value A of the three initial absorption measurement results. I asked. The remaining 5 mL was kept at 37 ° C. for 10 minutes, and undegraded casein was precipitated using the 1 mL by the precipitation method described above. This operation was performed four times to obtain four samples (n = 4). The absorption value after treatment at 280 nm in each supernatant was measured, and the average value A of the four absorption results after treatment was determined. Initial absorption average value A from absorption average value A after treatment. The value after subtraction was used as the activity value of evening proteinase.
残存活性 (%) は次式により算出した。  The residual activity (%) was calculated by the following equation.
残存活性値 (%) = [ (A-A0) /ADay。] X 100 Residual activity value (%) = [(AA 0 ) / A Day . ] X 100
ADay0:試験開始日の酵素活性値 A Day0 : Enzyme activity value on test start day
各酵素剤における酵素の残存活性値を表 3および 4に示す。  Tables 3 and 4 show the residual activity value of the enzyme in each enzyme preparation.
表 3 実施例 Table 3 Examples
期間  Period
4 6 7 8 9 10 12  4 6 7 8 9 10 12
1週間後 87 85 95 94 91 84 100 100 100 100 95 93 One week later 87 85 95 94 91 84 100 100 100 100 95 93
2週間後 2 weeks later
または 93 85 94 91 90 80 100 100 100 96 87 92 1力月後  Or 93 85 94 91 90 80 100 100 100 96 87 92 1 month later
単位 (%) 表 4 Unit (%) Table 4
Figure imgf000015_0001
Figure imgf000015_0001
単位 (%) 表 3、 4から明らかなように、 水溶性高分子有機固体は充分な酵素活性 安定化作用を示し、 水溶性低分子有機液体の酵素活性安定化作用とほぼ同 等であることが判明した。 また、 水溶性高分子有機固体と水溶性低分子有 機液体とをさまざまな割合で混合した場合においても、 充分な安定化作用 が得られることも判明した。  Unit (%) As is clear from Tables 3 and 4, the water-soluble high-molecular organic solid exhibits sufficient enzyme activity stabilizing action, and is almost equivalent to the enzyme activity stabilizing action of the water-soluble low-molecular organic liquid. There was found. It was also found that a sufficient stabilizing effect was obtained even when the water-soluble high-molecular organic solid and the water-soluble low-molecular organic liquid were mixed in various ratios.
試験例 2 (マルチパーパスソリューション中での浸透圧測定試験) Test example 2 (Osmotic pressure measurement test in multi-purpose solution)
実施例 1〜 9、 11および 12、 比較例 1〜 7および 14〜 16のコン タク卜レンズ用酵素剤をそれぞれマルチパーパスソリユーションに添加し、 その溶液の浸透圧を測定した。  The contact lens enzymatic agents of Examples 1 to 9, 11 and 12, and Comparative Examples 1 to 7 and 14 to 16 were respectively added to a multipurpose solution, and the osmotic pressure of the solution was measured.
マルチパーパスソリューションとしては、 アイネス (販売元:株式会社 メニコン) を使用し、 アイネス 2mLに対し各酵素剤を 80 L (2滴換 算量) 添加した。 浸透圧測定には HOSM— 1 (トーァエレクトロニクス 社 (TOA Electronics Ltd.) 製) を使用した。  As a multi-purpose solution, Ines (manufacturer: Menicon Co., Ltd.) was used, and 2 L of Ines was added to each of the enzyme preparations in an amount of 80 L (2 drops). HOSM-1 (TOA Electronics Ltd.) was used for the osmotic pressure measurement.
各溶液の浸透圧を表 5および 6に示す。 表 5  Tables 5 and 6 show the osmotic pressure of each solution. Table 5
Figure imgf000015_0002
Figure imgf000015_0002
単位 (m〇 sm/k g) 、 アイネス; 293mO sm/k g 表 6 Unit (m〇 sm / kg), Ines; 293mO sm / kg Table 6
Figure imgf000016_0001
Figure imgf000016_0001
単位 (mO sm/k g) 、 アイネス; 293mO sm/k g 酵素剤は 26倍 (80 L/2mL) へと希釈され、 全量から見れば少 量であるが、 表 5、 6から明らかなように、 プロピレングリコールやダリ セリンを多く含有する場合、 浸透圧が有意に高くなることが確認された。 一方、 水溶性高分子有機固体を多く含有する場合、 浸透圧はそれらよりも 明らかに低値であった。  Unit (mO sm / kg), Ines; 293mO sm / kg Enzyme is diluted 26-fold (80 L / 2 mL), which is small in total, but as evident from Tables 5 and 6, It was confirmed that when a large amount of propylene glycol or dalyserin was contained, the osmotic pressure was significantly increased. On the other hand, when a large amount of the water-soluble high molecular organic solid was contained, the osmotic pressure was clearly lower than those.
試験例 3 (コンタク卜レンズの D I A変化測定試験) Test example 3 (DIA change measurement test of contact lens)
前記各酵素剤に一定期間連続浸漬した場合のレンズの膨潤度合を測定し た。 測定は以下のように行った。  The degree of swelling of the lens when continuously immersed in each of the enzyme agents for a certain period was measured. The measurement was performed as follows.
アイネス 2mLに酵素剤 80 L (2滴換算量) を混和することにより、 処理液を調製した。 ついで、 各処理液にコンタクトレンズを浸漬した。 実 施例 3および比較例 1の酵素剤については、 浸漬から 1日後および 3日後 に、 実施例 11および 12、 ならびに比較例 3、 4および 5の酵素剤につ いては、 浸漬から 1日後および 4日後に、 また、 実施例 1、 2、 4、 5、 6、 7、 8および 9、 ならびに比較例 2、 6、 7、 14、 15および 16 の酵素剤については、 浸漬から 1日後および 5日後にコンタクトレンズの 直径 (D IA) を測定した。 試験では、 頻回交換レンズ アキュビュ一2 (ジョンソン エンド ジョンソン社製、 含水率 58%) を使用し、 処理 液は毎日 1回交換された。 D I A測定においては、 コンタクトレンズに付 いているマーキングを指標として直径 (A) を測定し、 ついで直径 (A) に垂直に交わる直径 (B) を測定する。 直径 (A) と直径 (B) の平均値 を D I A測定値とした。 A treatment solution was prepared by mixing 2 L of Ines with 80 L of enzyme (equivalent to 2 drops). Next, a contact lens was immersed in each treatment solution. The enzyme preparations of Example 3 and Comparative Example 1 were 1 day and 3 days after the immersion, and the enzyme preparations of Examples 11 and 12 and Comparative Examples 3, 4 and 5 were 1 day after the immersion. Four days later, and for the enzyme preparations of Examples 1, 2, 4, 5, 6, 7, 8 and 9, and Comparative Examples 2, 6, 7, 14, 15 and 16, 1 day and 5 days after immersion After a day, the diameter (DIA) of the contact lens was measured. In the test, a frequently interchangeable lens Accuview-1 (manufactured by Johnson & Johnson, water content 58%) was used, and the treatment solution was changed once daily. In DIA measurement, the diameter (A) is measured using the marking on the contact lens as an index, and then the diameter (B) perpendicular to the diameter (A) is measured. Average of diameter (A) and diameter (B) Was taken as the DIA measurement value.
処理後のレンズの D I A測定値を処理前のものと比較した結果を、 表 7 および 8に示す。 表 7  Tables 7 and 8 show the results of comparing the measured DIA values of the processed lens with those before the processing. Table 7
Figure imgf000017_0001
Figure imgf000017_0001
単 (mm) 表 8  Single (mm) Table 8
Figure imgf000017_0002
Figure imgf000017_0002
単位 (mm) 表 7、 8から明らかなように、 水溶性低分子有機液体を多く含有する場 合、 レンズを有意に膨潤 (変形) させることが判明した。 しかしながら、 水溶性高分子有機固体を多く含有する場合、 膨潤 (変形) させないことが 判明した。 興味深いことに、 平均分子量が約 2 0 0のポリエチレングリコ ール (液体) はレンズを膨潤 (変形) させるが、 平均分子量が 1 0 0 0以 上ではその変形を抑制できることが分かった。  Unit (mm) As is clear from Tables 7 and 8, it was found that when a large amount of water-soluble low-molecular-weight organic liquid is contained, the lens swells (deforms) significantly. However, it was found that swelling (deformation) did not occur when a large amount of water-soluble organic polymer solid was contained. Interestingly, it was found that polyethylene glycol (liquid) with an average molecular weight of about 200 swells (deforms) the lens, but that deformation can be suppressed above 100,000.
試験例 4 (コンタクトレンズ用液体酵素剤の粘性比較試験)  Test example 4 (viscosity comparison test of liquid enzyme preparation for contact lens)
実施例 1〜 9、 1 1および 1 2ならびに比較例 1〜7および 1 4〜1 6 の各酵素剤をガラス容器に入れてキャップをした。 ついで、 その容器を逆 さまにしたときの酵素溶液の落下状態を目視で観察し、 各酵素溶液の粘性 ^ を比較した。 結果を表 9および 1 0に示す。 表 9 Each of the enzyme preparations of Examples 1 to 9, 11 and 12 and Comparative Examples 1 to 7 and 14 to 16 was placed in a glass container and capped. Then reverse the container The falling state of the enzyme solution when it was cooled was visually observed, and the viscosity of each enzyme solution was compared. The results are shown in Tables 9 and 10. Table 9
Figure imgf000018_0001
表 1 0
Figure imgf000018_0001
Table 10
Figure imgf000018_0002
Figure imgf000018_0002
〇 容器を逆さまにした場合、 直ちに落下した酵素溶液。 酵素 Enzyme solution that immediately falls when the container is turned upside down.
△ 容器を逆さまにした場合、 1秒以内に容器を伝わって落下した酵素 溶液。  △ Enzyme solution that passed down the container within 1 second when the container was turned upside down.
X 容器を逆さまにした場合、 1秒経過しても落下しない酵素溶液。 X Enzyme solution that does not fall even after 1 second when the container is turned upside down.
<総合評価 > <Comprehensive evaluation>
実施例 1〜 9、 1 1および 1 2ならびに比較例 1〜7ぉょび1 4〜1 6 に関し、 前記試験例 1〜4の結果に基づいて各酵素剤の効果を総合的に評 価した。 各評価を表 1 1および 1 2に示す。 実施例 With respect to Examples 1 to 9, 11 and 12 and Comparative Examples 1 to 7 and 14 to 16, the effects of each enzyme preparation were comprehensively evaluated based on the results of Test Examples 1 to 4. . Each evaluation is shown in Tables 11 and 12. Example
効果  Effect
1 2 3 4 5 6 7 8 9 1 1 1 2 1 2 3 4 5 6 7 8 9 1 1 1 2
(ァ) 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇(A) 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇
(ィ) 〇 〇 〇 Δ 〇 〇 〇 Δ △ Δ Δ(Ii) 〇 〇 〇 Δ 〇 〇 〇 Δ △ Δ Δ
(ゥ) 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇(ゥ) 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇
(ェ) 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 総合評価 ◎ ◎ ◎ 〇 ◎ ◎ ◎ 〇 〇 〇 〇 (D) 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 Overall evaluation ◎ ◎ ◎ 〇 ◎ ◎ ◎ 〇 〇 〇 〇 〇
2 Two
Figure imgf000019_0001
表 1 1および 1 2における (ァ) 、 (ィ) 、 (ゥ) および (ェ) ならび に各記号は、 以下のとおりである。
Figure imgf000019_0001
(A), (a), (、), and (e) in Tables 11 and 12 and the respective symbols are as follows.
また、 (ァ) 〜 (ェ) の各項目に共通して、 それぞれの記号は、 〇:コ ンタクトレンズ用液体酵素剤として好ましい、 △:コンタクトレンズ用液 体酵素剤として使用し得る程度、 X :コンタクトレンズ用液体酵素剤とし て不適当、 である。  In addition, common to each of the items (a) to (e), each symbol is: 〇: Preferred as a liquid enzyme agent for contact lenses, Δ: Degree of use as a liquid enzyme agent for contact lenses, X : Not suitable as liquid enzyme preparation for contact lenses.
(ァ) レンズの膨潤度合を測定したもの (表 7および 8の結果に基づく) (A) Measured degree of lens swelling (based on the results in Tables 7 and 8)
〇 レンズ浸漬前後のサイズの変化が 0 . 0 5 mm以下 サ イ ズ The change in size before and after lens immersion is 0.05 mm or less
△ レンズ浸漬前後のサイズの変化が 0 . 0 5 mmより大きく 0 . 1 0 以下  △ Change in size before and after lens immersion is greater than 0.05 mm and 0.10 or less
X レンズ浸漬前後のサイズの変化が 0 . 1 0 mmより大きい (ィ) 浸透圧上昇を測定したもの (表 5および 6の結果に基づく) 〇 浸透圧が 450m〇 smZk g以下 X Change in size before and after immersion is greater than 0.10 mm (B) Measured osmotic pressure increase (based on the results in Tables 5 and 6) 浸透 Osmotic pressure is 450 m〇 smZkg or less
Δ 浸透圧が 45 OmOsmZkgより大きく 50 OmOsmZkg以下 X 浸透圧が 500m〇 sm/k gより大きい  Δ Osmotic pressure is greater than 45 OmOsmZkg and 50 OmOsmZkg or less X Osmotic pressure is 500 m〇 greater than sm / kg
(ゥ) 2週間後または 1力月後の酵素活性安定化を測定したもの (表 3お よび 4の結果に基づく)  (Ii) Stability of enzyme activity after 2 weeks or 1 month (based on the results in Tables 3 and 4)
〇 80%以上  〇 80% or more
△ 60%以上 80%未満  △ 60% or more and less than 80%
X 60 %未満  X less than 60%
(ェ) 粘性比較 (表 9および 10の結果に基づく)  (E) Viscosity comparison (based on the results in Tables 9 and 10)
〇 容器を逆さまにした場合、 直ちに落下した酵素溶液。  酵素 Enzyme solution that immediately falls when the container is turned upside down.
△ 容器を逆さまにした場合、 1秒以内に容器を伝わって落下した酵素 溶液。  △ Enzyme solution that passed down the container within 1 second when the container was turned upside down.
X 容器を逆さまにした場合、 1秒経過しても落下しない酵素溶液。 X Enzyme solution that does not fall even after 1 second when the container is turned upside down.
<総合評価の評価基準 > <Comprehensive evaluation criteria>
◎ 全ての項目が〇である場合。 該当する酵素剤は、 コンタクトレンズ 用液体酵素剤として非常に好ましい。  ◎ All items are 〇. Such enzyme preparations are highly preferred as liquid enzyme preparations for contact lenses.
〇 少なくとも 1つの項目が△であり、 残りの項目が〇である場合。 該 当する酵素剤は、 コンタクトレンズ用液体酵素剤として好ましい。  場合 At least one item is a △ and the remaining items are 〇. Such enzyme agents are preferred as liquid enzyme agents for contact lenses.
X 少なくとも 1つの項目が Xである場合。 該当する酵素剤は、 コンタ クトレンズ用液体酵素剤として不適当である。  X if at least one item is X. The corresponding enzyme preparation is not suitable as a liquid enzyme preparation for contact lenses.
試験例 1〜 4の結果ならびに表 11および 12に示した総合評価より、 実施例がコン夕クトレンズ用液体酵素剤として有効であることが確認され た。 ここで、 実施例のさらなる有効性を確認するため、 実施例 11および 12ならびに比較例 8〜13の酵素剤を使用して下記の試験を実施した。 試験例 5 (保存効力試験) From the results of Test Examples 1 to 4 and the comprehensive evaluations shown in Tables 11 and 12, it was confirmed that the examples were effective as liquid enzyme preparations for contact lenses. Here, in order to confirm the further effectiveness of the examples, the following tests were performed using the enzyme preparations of Examples 11 and 12 and Comparative Examples 8 to 13. Test Example 5 (Preservation efficacy test)
試験菌として、 シユードモナス ァエルギノ一サ I FO 13275、 黄色ブドウ球菌 I FO 13276、 大腸菌 I FO 3972、 キヤ ンデイダ アルビカンス I FO 1594、 ァスペルギルス ニガ一 ATCC 16404の 5種類の菌懸濁液を準備した。 試験試料としては、 実施例 1 1および 12ならびに比較例 8〜 13の酵素剤を使用した。 チュ —ブに分注した試験試料 10 mLに対し、 それぞれ菌懸濁液を 100 L ずつ接種し、 混和した。 菌を接種した各試験試料を 22 のインキュベー 夕一に入れ、 培養した。 接種菌数を測定するため、 菌を接種した生理食塩 液 (別途準備) を生理食塩水で 10倍に段階希釈して培地 (細菌: SCD LP、 真菌: SDLP) にァスペルギルス ニガ一は塗抹し、 それ以外は 混釈した。 S CD LP培地は 32 ± 2 で 6日間、 30 ?培地は22± 2 °Cで 5日間培養した (各群につき 3枚) 。 接種 14日目に菌を接種した 試験試料から 0. 5mLを採取し、 生菌数を測定するため生理食塩液で 1 0倍に段階希釈して培地 (細菌: SCDLP、 真菌: SDLP) にァスぺ ルギルス 二ガーは塗抹し、 それ以外は混釈した。 3〇0し?培地は32 土 2 で 6日間、 S D L P培地は 22 ± 2°Cで 5日間培養した (各群につ き 3枚) 。 培養終了後にコロニーの数を数え、 3枚の平均値から試料中の 生菌数を計算した。 ただし、 細菌については 300 c f u /プレート以下 のプレート、 真菌については 100 c f u /プレート以下のプレートを力 接種菌数と 14日目の生菌数より、 対数減少 (log reduction) = 1 o g (接種菌数 /14日目の菌数) を求め、 保存効力とした。 結果を表 13 に示す。 表 13 実施例 比較例 Five types of bacterial suspensions of Pseudomonas aeruginosa IFO 13275, Staphylococcus aureus IFO 13276, Escherichia coli IFO 3972, Candida albicans IFO 1594, and Aspergillus niger ATCC 16404 were prepared as test bacteria. As test samples, the enzyme preparations of Examples 11 and 12 and Comparative Examples 8 to 13 were used. 100 L of the bacterial suspension was inoculated to 10 mL of the test sample dispensed into the tube and mixed. Each test sample inoculated with the bacteria was placed in 22 incubators overnight and cultured. To measure the number of inoculated bacteria, a saline solution inoculated with the bacteria (prepared separately) was serially diluted 10-fold with physiological saline, and Aspergillus niger was spread on the medium (bacteria: SCD LP, fungi: SDLP). Others were pruned. S CD LP medium at 32 ± 2 for 6 days, 30? The medium was cultured at 22 ± 2 ° C for 5 days (3 per group). On the 14th day after inoculation, 0.5 mL was collected from the test sample inoculated with the bacteria, serially diluted 10-fold with physiological saline to determine the number of viable bacteria, and placed in a medium (bacterial: SCDLP, fungus: SDLP). Surgirus Niger was smeared and the others were poured. 3〇0? The medium was cultured at 32 soil 2 for 6 days, and the SDLP medium was cultured at 22 ± 2 ° C for 5 days (3 per group). After completion of the culture, the number of colonies was counted, and the number of viable bacteria in the sample was calculated from the average value of the three colonies. However, plates of 300 cfu / plate or less for bacteria and plates of 100 cfu / plate or less for fungi are used.Log reduction = 1 og (inoculated bacteria) (Number of bacteria on the 14th day). Table 13 shows the results. Table 13 Example Comparative Example
11 12 8 9 10 11 12 13  11 12 8 9 10 11 12 13
シユードモナス ァエルギノ一サ Pseudomonas aeruginosa
>4.98 >4.98 >5.09 >4.79 >4.79 >4.79 >5.09 >5.09  > 4.98> 4.98> 5.09> 4.79> 4.79> 4.79> 5.09> 5.09
I FO 13275  I FO 13275
黄色ブドウ球菌 Staphylococcus aureus
>5.10 >5.10 0.93 2.37 2.30 2.29 1.02 2.02  > 5.10> 5.10 0.93 2.37 2.30 2.29 1.02 2.02
I FO 13276  I FO 13276
b 大腸菌  b E. coli
>5.04 >5.04 3.26 2.89 3.60 4.03 2.29 3.00  > 5.04> 5.04 3.26 2.89 3.60 4.03 2.29 3.00
I FO 3972  I FO 3972
キャンディダ アルビカンス Candida Albicans
2.85 5.26 0.34 0.88 0.82 0.69 0.78 1.25  2.85 5.26 0.34 0.88 0.82 0.69 0.78 1.25
I FO 1594  I FO 1594
ァスペルギルス 二ガー Aspergils Niger
2.08 1.04 2.83 2.04 1.76 1.64 2.78 2.75  2.08 1.04 2.83 2.04 1.76 1.64 2.78 2.75
ATCC 16404 ATCC 16404
表 1 3から明らかなように、 実施例 1 1および 1 2は、 すべての細菌に 対して log reduct ionが 4以上、 かつすベての真菌に対して 1以上であり、 製剤としての保存効力に優れることが確認された。 一方、 比較例 8〜1 3 では、 実施例 1 1および 1 2のようにすべての細菌に対して 4以上、 かつ すべての真菌に対して 1以上の log reduc t ionを得られるものはなかった。 試験例 5における実施例と比較例との組成の最も大きな違いは、 P E G # 1 0 0 0の配合量であり、 P E G # 1 0 0 0の配合量が製剤の保存効力に 寄与した可能性は非常に高いという知見が得られた。 産業上の利用可能性 As is clear from Table 13, Examples 11 and 12 show that the log reduction is 4 or more for all bacteria and 1 or more for all fungi, It was confirmed that it was excellent. On the other hand, in Comparative Examples 8 to 13, none of Examples 11 and 12 obtained a log reduction of 4 or more for all bacteria and 1 or more for all fungi. . The largest difference in the composition between the Example and Comparative Example in Test Example 5 is the amount of PEG # 100, and it is possible that the amount of PEG # 100 may have contributed to the storage efficiency of the formulation. The finding was very high. Industrial applicability
本発明のコンタクトレンズ用液体酵素剤に含有される水溶性高分子有機 固体は、 コンタクトレンズにとりこまれることがなく、 レンズが膨潤する などの悪影響を及ぼさない。 そのため、 本発明のコンタクトレンズ用液体 酵素剤は、 レンズ機能を損ねることがない。 また、 本発明のコンタクトレ ンズ用液体酵素剤は、 酵素剤を滴下した際の処理液浸透圧の上昇を防ぎ、 レンズへの悪影響や、 誤用時の眼刺激を抑えることができる。 さらに本発 明のコン夕クトレンズ用液体酵素剤は、 従来のコンタクトレンズ用液体酵 素剤 (水溶性低分子有機液体 +タンパク質分解酵素) と同様の酵素活性安 定化作用を有する。  The water-soluble high molecular organic solid contained in the liquid enzyme agent for contact lenses of the present invention is not taken up by the contact lens and does not have any adverse effect such as swelling of the lens. Therefore, the liquid enzyme agent for contact lenses of the present invention does not impair the lens function. In addition, the liquid enzyme preparation for contact lenses of the present invention can prevent an increase in the osmotic pressure of the treatment liquid when the enzyme preparation is dropped, and can suppress adverse effects on the lens and eye irritation during misuse. Furthermore, the liquid enzyme preparation for contact lenses of the present invention has the same enzyme activity stabilizing action as the conventional liquid enzyme preparation for contact lenses (water-soluble low-molecular organic liquid + proteolytic enzyme).
以上のように、 本発明のコンタクトレンズ用液体酵素剤は、 非常に優れ た効果を有する。  As described above, the liquid enzyme agent for contact lenses of the present invention has a very excellent effect.

Claims

言青求の範囲 Scope of Word
1. 平均分子量が 8 0 0〜 1 0 0 0 0 0の水溶性高分子有機固体、 粘性調 整剤および酵素を含むコンタクトレンズ用液体酵素剤。 1. A liquid enzyme preparation for contact lenses containing a water-soluble organic polymer solid having an average molecular weight of 800 to 1000, a viscosity modifier and an enzyme.
2. 前記水溶性高分子有機固体がポリアルキレンダリコール類である請求 の範囲第 1項記載のコンタクトレンズ用液体酵素剤。  2. The liquid enzyme agent for contact lenses according to claim 1, wherein the water-soluble organic polymer solid is a polyalkylene dalicol.
3. 前記水溶性高分子有機固体がポリエチレングリコ一ルまたはポリェチ レングリコ一ルモノメチルェ一テルである請求の範囲第 1項記載のコン タクトレンズ用液体酵素剤。  3. The liquid enzyme agent for contact lenses according to claim 1, wherein the water-soluble high molecular organic solid is polyethylene glycol or polyethylene glycol monomethyl ether.
4. 前記水溶性高分子有機固体を 5〜 4 5 wZw%含有する請求の範囲第 1項、 第 2項または第 3項記載のコンタクトレンズ用液体酵素剤。 4. The liquid enzyme agent for a contact lens according to claim 1, wherein the water-soluble polymer organic solid is contained in an amount of 5 to 45 wZw%.
5. 前記粘性調整剤が水溶性低分子有機液体である請求の範囲第 1項記載 のコンタクトレンズ用液体酵素剤。 5. The liquid enzyme agent for contact lenses according to claim 1, wherein the viscosity modifier is a water-soluble low molecular weight organic liquid.
6. 前記粘性調整剤を 1 5〜 4 5 w/w%含有する請求の範囲第 1項記載 のコンタクトレンズ用液体酵素剤。  6. The liquid enzyme agent for contact lenses according to claim 1, wherein the viscosity adjusting agent is contained in an amount of 15 to 45 w / w%.
PCT/JP2003/009426 2002-07-29 2003-07-25 Liquid enzyme preparation for contact lenses WO2004011993A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2004524142A JP4402593B2 (en) 2002-07-29 2003-07-25 Liquid enzyme for contact lenses
AU2003255159A AU2003255159A1 (en) 2002-07-29 2003-07-25 Liquid enzyme preparation for contact lenses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002219934 2002-07-29
JP2002-219934 2002-07-29

Publications (1)

Publication Number Publication Date
WO2004011993A1 true WO2004011993A1 (en) 2004-02-05

Family

ID=31184745

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2003/009426 WO2004011993A1 (en) 2002-07-29 2003-07-25 Liquid enzyme preparation for contact lenses

Country Status (3)

Country Link
JP (1) JP4402593B2 (en)
AU (1) AU2003255159A1 (en)
WO (1) WO2004011993A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009256214A (en) * 2008-04-11 2009-11-05 Senka Pharmacy:Kk Polyethylene glycol derivative, and method for producing its intermediate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0829744A (en) * 1994-07-20 1996-02-02 Seiko Epson Corp Cleaning composition for contact lens, storing solution composition for contact lens, cleaning method of contact lens and disinfecting method of contact lens
WO1996040854A1 (en) * 1995-06-07 1996-12-19 Alcon Laboratories, Inc. Stable liquid enzyme compositions and methods of use in contact lens cleaning and disinfecting systems

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0829744A (en) * 1994-07-20 1996-02-02 Seiko Epson Corp Cleaning composition for contact lens, storing solution composition for contact lens, cleaning method of contact lens and disinfecting method of contact lens
WO1996040854A1 (en) * 1995-06-07 1996-12-19 Alcon Laboratories, Inc. Stable liquid enzyme compositions and methods of use in contact lens cleaning and disinfecting systems

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009256214A (en) * 2008-04-11 2009-11-05 Senka Pharmacy:Kk Polyethylene glycol derivative, and method for producing its intermediate

Also Published As

Publication number Publication date
AU2003255159A1 (en) 2004-02-16
JPWO2004011993A1 (en) 2005-11-24
JP4402593B2 (en) 2010-01-20

Similar Documents

Publication Publication Date Title
EP1796744B1 (en) Compositions containing trialkanolamine alkoxylate buffer
JP2000047156A (en) Disinfectant liquid for contact lens
JP3697294B2 (en) Cleaning and disinfecting contact lenses
KR20010104325A (en) Fast Acting Disinfectant and Cleaner
JPS6185301A (en) Disinfectant preserving solution for contact lens
JP3698832B2 (en) Contact lens solution
JP2003160482A (en) Ophthalmic solution and contact lens solution
US4490389A (en) Contact lens preserving solution containing ascorbic acid or salts thereof
WO2006026170A1 (en) Compositions containing n,n,n&#39;,n&#39;-tetrakis(hydroxyalkyl)diamine- or n,n,n&#39;,n&#39;-tetrakis(hydroxyalkoxy) diamine-based buffers
US4510065A (en) Soft contact lens preservative system, prophylactic cleaner and method
JP4781398B2 (en) Contact lens solution
JPH0892017A (en) Solution preparation for contact lens
US4581379A (en) Contact lens preserving solution
WO2004011993A1 (en) Liquid enzyme preparation for contact lenses
AU2012253546B2 (en) Ophthalmic system with synergistic properties
JPH09206362A (en) Sterilizing and cleaning composition for contact lens and sterilizing and cleaning method for contact lens using the same
WO1998020912A1 (en) Treatment composition for contact lenses and method for treating contact lenses with the same
US4581374A (en) Contact lens preserving solution
JP4174578B2 (en) Contact lens solution
JP2001264707A (en) Disinfecting and preserving solution for contact lens
JP2001242428A (en) Liquid agent for contact lens and method for cleaning, disinfecting and preserving soft contact lens
JP2851405B2 (en) Cleaning and / or preservative for contact lenses
JP2000084052A (en) Solution for contact lens
JPS6175319A (en) Contact lens detergent and cleaning method
JPH11322515A (en) Solution for contact lens

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004524142

Country of ref document: JP

122 Ep: pct application non-entry in european phase